Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
Jashin J. Wu, Arthur Kavanaugh, Mark Lebwohl, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 6, pp. 797-806
Open Access | Times Cited: 109
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Yuxiong Jiang, Youdong Chen, Qian Yu, et al.
BioDrugs (2023) Vol. 37, Iss. 1, pp. 35-55
Open Access | Times Cited: 56
Disease modification in inflammatory skin disorders: opportunities and challenges
Thomas Bieber
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 662-680
Closed Access | Times Cited: 43
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
Bapi Pahar, Stefania Madonna, Arpita Das, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 517-517
Open Access | Times Cited: 90
Aberrations in Lipid Expression and Metabolism in Psoriasis
Julia Nowowiejska, Anna Baran, Iwona Flisiak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6561-6561
Open Access | Times Cited: 62
Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review
Jörg C. Prinz, Siew Eng Choon, C.E.M. Griffiths, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 2, pp. 256-273
Open Access | Times Cited: 60
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies
Francesco Bellinato, Paolo Gisondi, Alessandro Mantovani, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 7, pp. 1277-1288
Open Access | Times Cited: 40
Novel Synergistic Approach: Tazarotene-Calcipotriol-Loaded-PVA/PVP-Nanofibers Incorporated in Hydrogel Film for Management and Treatment of Psoriasis
S.S. Thakur, Md Meraj Anjum, Shweta Jaiswal, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 2, pp. 997-1014
Closed Access | Times Cited: 33
Managing the Patient with Psoriasis and Metabolic Comorbidities
Francesco Bellinato, Martina Maurelli, Davide Geat, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 4, pp. 527-540
Open Access | Times Cited: 8
Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review
Annika Smith, Ayşegül Yağcı, Deborah Yi, et al.
Dermatology and Therapy (2025)
Open Access | Times Cited: 1
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules
Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
Biologics (2021) Vol. Volume 15, pp. 247-253
Open Access | Times Cited: 48
Psoriasis: Interplay between dysbiosis and host immune system
Bhupinder Kapoor, Monica Gulati, Pooja Rani, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 11, pp. 103169-103169
Closed Access | Times Cited: 35
Comorbidity in Adult Psoriasis: Considerations for the Clinician
Christine Daugaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Psoriasis Targets and Therapy (2022) Vol. Volume 12, pp. 139-150
Open Access | Times Cited: 34
Lipidic Profile Changes in Exosomes and Microvesicles Derived From Plasma of Monoclonal Antibody-Treated Psoriatic Patients
Giovanni Paolino, Sandra Buratta, Santo Raffaele Mercuri, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 32
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease
Antonio Olveira, Salvador Augustín, Salvador Benlloch, et al.
Life (2023) Vol. 13, Iss. 2, pp. 419-419
Open Access | Times Cited: 17
The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies
Diana Sabina Radaschin, Alin Laurenţiu Tatu, Alina Viorica Iancu, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1619-1619
Open Access | Times Cited: 6
Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?
Johanna Heitmann, Verena Frings, Andreas Geier, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 4, pp. 517-528
Open Access | Times Cited: 35
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
Aikaterini Tsiogka, Stamatios Gregoriou, Alexander Stratigos, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 318-318
Open Access | Times Cited: 14
The ‘inflammazone’ in chronic inflammatory diseases: psoriasis and sarcoidosis
Phei Er Saw, Erwei Song
Trends in Immunology (2025)
Closed Access
Association Between Systemic Inflammation, Metabolic Syndrome and Quality of Life in Psoriasis Patients
Maria-Lorena Mustață, Carmen-Daniela Neagoe, Virginia-Maria Rădulescu, et al.
Life (2025) Vol. 15, Iss. 2, pp. 212-212
Open Access
Psoriasis and Comorbidity of Mental Pathology: Parallels and Intersections
И. С. Владимирова, Л. С. Круглова, E.D. Kochereva, et al.
Psikhiatriya (2025) Vol. 22, Iss. 6, pp. 82-88
Closed Access
Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers
Valeria Brazzelli, Pamela Maffioli, V. Bolcato, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 31
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies
Deepak Balak, Stefano Piaserico, Ismail Kasujee
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 151-168
Open Access | Times Cited: 30
Psoriasis and Cardiovascular Diseases: An Immune-Mediated Cross Talk?
Gloria Orlando, Barbara Molon, Antonella Viola, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis
Yan Wang, Jinxin Zang, Chen Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top